Association between axial length of the eye and primary angle closure glaucoma

Association between axial length of the eye and primary angle closure glaucoma.

BACKGROUND Angle closure glaucoma is emerging as a leading cause of blindness in Asia. OBJECTIVE To compare the ocular axial length of normal individuals and the subjects with primary angle closure glaucoma. This study has been conducted to determine axial length of eye as a risk factor of primary angle closure glaucoma. MATERIALS AND METHODS A cross-sectional comparative study was carried ...

Association of Matrix Metalloproteinase-9 (MMP9) Variants with Primary Angle Closure and Primary Angle Closure Glaucoma

Shorter axial length observed in patients with primary angle closure glaucoma (PACG) might be due to altered matrix metalloproteinase-9 (MMP9) activity resulting in ECM remodeling during eye growth and development. This study aimed to evaluate common variants in MMP9 for association with PACG. Six tag SNPs of MMP9 were genotyped in a Chinese sample of 1,030 cases, including 572 PACG and 458 pri...

Primary Angle Closure Glaucoma

SCIENTIFIC REPORT Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma

Aims: To study the effect of axial length on the hypotensive effect of latanoprost in primary open angle glaucoma (POAG) in a prospective, observational study. Methods: The authors measured axial length and baseline intraocular pressure (IOP) of 109 eyes with POAG, and then repeated the IOP measurements at 1, 3, and 6 months after starting treatment with latanoprost. Results: The mean IOP level...

Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma.

AIMS To study the effect of axial length on the hypotensive effect of latanoprost in primary open angle glaucoma (POAG) in a prospective, observational study. METHODS The authors measured axial length and baseline intraocular pressure (IOP) of 109 eyes with POAG, and then repeated the IOP measurements at 1, 3, and 6 months after starting treatment with latanoprost. RESULTS The mean IOP leve...